These ADCs, called EV20/MMAF and EV20-sss-vc/MMAF respectively, displayed potent antitumor activity in melanoma and breast carcinoma resistant to anti-HER-2 therapies [13,14] and liver cancer [28]. This evidence concerns the gene ERBB2 and melanoma.